Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schroeder

Showing results (701-710 of 718) with videos related to

Pageof 72
Sort By:
Blood Advances|December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Journal of Medicinal Chemistry|February 2, 2022
Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype HybridizationEmily C Cherney, Liping Zhang, Julian Lo, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitorsKyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Journal of Medicinal Chemistry|March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamilyGretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative NeoplasmsHonghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Regional Anesthesia and Pain Medicine|September 23, 2021
A multisociety organizational consensus process to define guiding principles for acute perioperative pain managementEdward R Mariano, David M Dickerson, Joseph W Szokol, et al.
Nature Communications|August 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyJonas S Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Nature Genetics|February 15, 2001
A candidate prostate cancer susceptibility gene at chromosome 17pS V Tavtigian, J Simard, D H Teng, et al.
Pageof 72

Showing results (701-710 of 718) with videos related to

Sort By:
Pageof 72
Blood Advances|December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Blood Cancer Discovery|October 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.
Journal of Medicinal Chemistry|February 2, 2022
Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype HybridizationEmily C Cherney, Liping Zhang, Julian Lo, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitorsKyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Journal of Medicinal Chemistry|March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamilyGretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative NeoplasmsHonghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Regional Anesthesia and Pain Medicine|September 23, 2021
A multisociety organizational consensus process to define guiding principles for acute perioperative pain managementEdward R Mariano, David M Dickerson, Joseph W Szokol, et al.
Nature Communications|August 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyJonas S Heitmann, Claudia Tandler, Maddalena Marconato, et al.
Nature Genetics|February 15, 2001
A candidate prostate cancer susceptibility gene at chromosome 17pS V Tavtigian, J Simard, D H Teng, et al.
Pageof 72